Resistance to hypoxia-induced, BNIP3-mediated cell death contributes to an increase in a CD133-positive cell population in human glioblastomas in vitro

Journal of Neuropathology and Experimental Neurology

Volumn 71, Issue 12, 2012, Pages 1086-1099

  Kahlert, Ulf Dietrich ^a,c   MacIaczyk, Donata ^a   Dai, Fangping ^a   Claus, Rainer ^a   Firat, Elke ^a   Doostkam, Soroush ^a   Bogiel, Tomasz ^a,d   Carro, Maria Stella ^a   Döbrössy, Mate ^a   Herold Mende, Christel ^b   Niedermann, Gabriele ^a   Prinz, Marco ^a,c   Nikkhah, Guido ^a   MacIaczyk, Jaroslaw ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY OF FREIBURG   (Germany)

^d Military Clinical Hospital Bydgoszcz   (Poland)

Author keywords

Apoptosis; BNIP3; Brain tumor stemlike cells; CD133; Glioblastoma; Hypoxia; Promoter methylation

Indexed keywords

AZACITIDINE; CD133 ANTIGEN; PROTEIN BNIP3;

APOPTOSIS; ARTICLE; CLONOGENESIS; ENVIRONMENTAL FACTOR; GENE EXPRESSION; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; OXYGEN TENSION; PRIORITY JOURNAL;

ANTIGENS, CD; ANTIMETABOLITES, ANTINEOPLASTIC; AZACITIDINE; BRAIN NEOPLASMS; CELL DEATH; CELL HYPOXIA; CELL LINE; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; DNA METHYLATION; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; GLYCOPROTEINS; HUMANS; MEMBRANE PROTEINS; PEPTIDES; PROTO-ONCOGENE PROTEINS; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 84870813786     PISSN: 00223069     EISSN: 15546578     Source Type: Journal    
DOI: 10.1097/NEN.0b013e3182772d83     Document Type: Article

References (52)

1. Darefsky AS, King JT Jr, Dubrow R. Adult glioblastoma multiforme survival in the temozolomide era: A population-based analysis of surveillance, epidemiology, and end results registries. Cancer 2012;118: 2163-72
2. Lawrence YR, Mishra MV, Werner-Wasik M, et al. Improving prognosis of glioblastoma in the 21st century: Who has benefited most? Cancer 2012;118:4228-34
3. Singh SK, Hawkins C, Clarke ID, et al. Identification of human brain tumour initiating cells. Nature 2004;432:396-401
4. Pistollato F, Abbadi S, Rampazzo E et al. Intratumoral hypoxic gradient drives stem cells distribution and MGMT expression in glioblastoma. Stem Cells 2010;28:851-62
5. Fotovati A, Abu-Ali S, Wang P-S, et al. YB-1 bridges neural stem cells and brain tumor-initiating cells via its roles in differentiation and cell growth. Cancer Res 2011;71:5569-78
6. Liu G, Yuan X, Zeng Z, et al. Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma. Mol Cancer 2006;5:67
7. Bao S, Wu Q, McLendon RE, et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006;444:756-60
8. Hemmati HD, Nakano I, Lazareff JA, et al. Cancerous stem cells can arise from pediatric brain tumors. Proc Natl Acad Sci USA 2003;100: 15178-83
9. Panchision DM. The role of oxygen in regulating neural stem cells in development and disease. J Cell Physiol 2009;220:562-68
10. Mohyeldin A, Garzón-Muvdi T, Quiñones-Hinojosa A. Oxygen in stem cell biology: A critical component of the stem cell niche. Cell Stem Cell 2010;7:150-61
11. Ezashi T, Das P, Roberts RM. Low O2 tensions and the prevention of differentiation of hES cells. Proc Natl Acad Sci USA 2005;102:4783-88
12. Pistollato F, Chen H-L, Schwartz PH, et al. Oxygen tension controls the expansion of human CNS precursors and the generation of astrocytes and oligodendrocytes. Mol Cell Neurosci 2007;35:424-35
13. Jensen RL. Brain tumor hypoxia: Tumorigenesis, angiogenesis, imaging, pseudoprogression, and as a therapeutic target. J Neurooncol 2009;92: 317-35
14. Chi J-T, Wang Z, Nuyten DSA, et al. Gene expression programs in response to hypoxia: Cell type specificity and prognostic significance in human cancers. PLoS Med 2006;3:e47
15. Bar EE, Lin A, Mahairaki V, et al. Hypoxia increases the expression of stem-cell markers and promotes clonogenicity in glioblastoma neurospheres. Am J Pathol 2010;177:1491-502
16. Griguer CE, Oliva CR, Gobin E, et al. CD133 is a marker of bioenergetic stress in human glioma. PLoS ONE 2008;3:e3655
17. Gustafsson MV, Zheng X, Pereira T, et al. Hypoxia requires notch signaling to maintain the undifferentiated cell state. Dev Cell 2005;9:617-28
18. Covello KL, Kehler J, Yu H, et al. HIF-2alpha regulates Oct-4: Effects of hypoxia on stem cell function, embryonic development, and tumor growth. Genes Dev 2006;20:557-70
19. Sun P, Xia S, Lal B et al. DNER, an epigenetically modulated gene, regulates glioblastoma-derived neurosphere cell differentiation and tumor propagation. Stem Cells 2009;27:1473-86
20. Campos B, Wan F, Farhadi M, et al. Differentiation therapy exerts antitumor effects on stem-like glioma cells. Clin Cancer Res 2010;16: 2715-28
21. Bar EE, Chaudhry A, Lin A, et al. Cyclopamine-mediated hedgehog pathway inhibition depletes stem-like cancer cells in glioblastoma. Stem Cells 2007;25:2524-33
22. Schreck KC, Taylor P, Marchionni L et al. The Notch target Hes1 directly modulates Gli1 expression and Hedgehog signaling: A potential mechanism of therapeutic resistance. Clin Cancer Res 2010;16:6060-70
23. Dull T, Zufferey R, Kelly M, et al. A third-generation lentivirus vector with a conditional packaging system. J Virol 1998;72:8463-71
24. Sarbassov DD, Guertin DA, Ali SM, et al. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 2005;307: 1098-101
25. Sastry L, Johnson T, Hobson MJ, et al. Titering lentiviral vectors: Comparison of DNA, RNA and marker expression methods. Gene Ther 2002;9:1155-62
26. Cheli Y, Giuliano S, Fenouille N, et al. Hypoxia and MITF control metastatic behavior in mouse and human melanoma cells. Oncogene 2012;31:2461-70
27. Benita Y, Kikuchi H, Smith AD, et al. An integrative genomics approach identifies hypoxia inducible factor-1 (HIF-1)-target genes that form the core response to hypoxia. Nucleic Acids Res 2009;37:4587-602
28. Fukasawa M, Tsuchiya T, Takayama E, et al. Identification and characterization of the hypoxia-responsive element of the human placental 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase gene. J Biochem 2004;136:273-77
29. Maksimovic J, Gordon L, Oshlack A. SWAN: Subset quantile within-array normalization for Illumina Infinium HumanMethylation450 BeadChips. Genome Biol 2012;13:R44
30. Hegi ME, Diserens A-C, Gorlia T, et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 2005;352: 997-1003
31. Stupp R, Hegi ME, Mason WP, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-Year analysis of the EORTC-NCIC trial. Lancet Oncol 2009;10:459-66
32. Kang M-K, Kang S-K. Tumorigenesis of chemotherapeutic drug-resistant cancer stem-like cells in brain glioma. Stem Cells Dev 2007;16:837-47
33. Wurmser AE, Palmer TD, Gage FH. Neuroscience. Cellular interactions in the stem cell niche. Science 2004;304:1253-55
34. Semenza GL. Regulation of mammalian O2 homeostasis by hypoxiainducible factor 1. Annu Rev Cell Dev Biol 1999;15:551-78
35. Collingridge DR, Piepmeier JM, Rockwell S, et al. Polarographic measurements of oxygen tension in human glioma and surrounding peritumoural brain tissue. Radiother Oncol 1999;53:127-31
36. Evans SM, Judy KD, Dunphy I, et al. Hypoxia is important in the biology and aggression of human glial brain tumors. Clin Cancer Res 2004;10: 8177-84
37. Rampling R, Cruickshank G, Lewis AD, et al. Direct measurement of pO2 distribution and bioreductive enzymes in human malignant brain tumors. Int J Radiat Oncol Biol Phys 1994;29:427-31
38. Beier D, Hau P, Proescholdt M, et al. CD133(+) and CD133(-) glioblastomaderived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Res 2007;67:4010-15
39. Jaksch M, Múnera J, Bajpai R, et al. Cell cycle-dependent variation of a CD133 epitope in human embryonic stem cell, colon cancer, and melanoma cell lines. Cancer Res 2008;68:7882-86
40. Joo KM, Kim SY, Jin X, et al. Clinical and biological implications of CD133-positive and CD133-negative cells in glioblastomas. Lab Invest 2008;88:808-15
41. Sun Y, Kong W, Falk A, et al. CD133 (Prominin) negative human neural stem cells are clonogenic and tripotent. PLoS ONE 2009;4:e5498
42. Kelly JJP, Stechishin O, Chojnacki A, et al. Proliferation of human glioblastoma stem cells occurs independently of exogenous mitogens. Stem Cells 2009;27:1722-33
43. Nishide K, Nakatani Y, Kiyonari H, et al. Glioblastoma formation from cell population depleted of Prominin1-expressing cells. PLoS ONE 2009; 4:e6869
44. McCord AM, Jamal M, Shankavaram UT, et al. Physiologic oxygen concentration enhances the stem-like properties of CD133+ human glioblastoma cells in vitro. Mol Cancer Res 2009;7:489-97
45. Campos B, Zeng L, Daotrong PH, et al. Expression and regulation of AC133 and CD133 in glioblastoma. Glia 2011;59:1974-86
46. Platet N, Liu SY, Atifi ME, et al. Influence of oxygen tension on CD133 phenotype in human glioma cell cultures. Cancer Lett 2007;258:286-90
47. Kolenda J, Jensen SS, Aaberg-Jessen C, et al. Effects of hypoxia on expression of a panel of stem cell and chemoresistance markers in glioblastoma-derived spheroids. J Neurooncol 2011;103:43-58
48. Mathieu J, Zhang Z, Zhou W, et al. HIF induces human embryonic stem cell markers in cancer cells. Cancer Res 2011;71:4640-52
49. Okami J, Simeone DM, Logsdon CD. Silencing of the hypoxia-inducible cell death protein BNIP3 in pancreatic cancer. Cancer Res 2004;64: 5338-46
50. Shaida N, Launchbury R, Boddy JL, et al. Expression of BNIP3 correlates with hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha and the androgen receptor in prostate cancer and is regulated directly by hypoxia but not androgens in cell lines. Prostate 2008;68:336-43
51. Kreth S, Thon N, Kreth FW. Epigenetics in human gliomas. Cancer Lett 2012 [Epub ahead of print] doi:10.1016/j.canlet.2012.04.008
52. Herman JG, Baylin SB. Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 2003;349:2042-54